HE4 is associated with clinical risk prognostic factors and survival outcome in primary fallopian tube carcinoma patients

Autor: Dong Mi, Yuexiang Zhang, Shuqin Chen
Rok vydání: 2022
Předmět:
Zdroj: Journal of Obstetrics and Gynaecology Research. 48:1897-1903
ISSN: 1447-0756
1341-8076
DOI: 10.1111/jog.15293
Popis: To explore whether HE4 was associated with clinical risk prognostic factors and survival outcome in primary fallopian tube carcinoma patients.Ninety-six primary fallopian tube carcinoma (PFTC) patients from March 2011 to June 2019 were enrolled in this study. Serum CA125 and HE4 concentrations were measured at four time points including primary diagnosis, postsurgery, pre-recurrence, and recurrence. The relations between clinical risk prognostic factors with HE4 concentrations were investigated, and multivariate survival analysis was used to calculate the hazard ratios between HE4 levels with recurrence-free survival and overall survival.HE4 were significantly elevated in poor performance status, advanced stage, high histological grade and residual tumor diameter1 cm, and positive lymph node status, respectively, compared with those in well performance status, early stage, low histological grade, residual tumor diameter ≤1 cm, and negative lymph node status, respectively. Multivariate survival analysis indicated serum HE4 can predict outcome of recurrence-free survival and overall survival with hazard ratios of 9.92 (95% confidence interval [CI]: 2.95-33.32) and 3.12 (95% CI: 1.07-9.08), respectively.HE4 is associated with clinical risk prognostic factors in PFTC and contributes to predict survival outcome in PFTC cases.
Databáze: OpenAIRE
Externí odkaz: